Now, a united team of investigators at Simon Fraser University in Burnaby, British Columbia, has developed a microfluidic chip that may trap individual cancers cells and investigate the ability of various pump-blocking medicines to overcome drug resistance. This new ‘lab-on-a-chip’ device could confirm useful for learning multiple drug level of resistance and for selecting the appropriate therapy for a given patient. Related StoriesStudy displays why malignancy anemia therapy stimulates tumor growthDiscovery may open up new doors to focusing on how melanoma grows and spreadsUCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling testsPaul Li, Ph.D., and his co-workers developed the dime-size chip to choose and retain individual cancer cells within a chamber that can be dosed with drugs loaded into an on-chip reservoir.‘The full group of data will now help guide planning next-stage clinical development actions, as well as discussions with regulatory authorities.’.

Publication examines complex structures of synaptic regions highly Synapses are bulbous structures where two neurons communicate. Neurotransmitter molecules released from the presynaptic terminal of 1 neuron diffuse to the postsynaptic terminal on the additional, binding to receptors that result in propagation or modulation of the signal.

Other entries from category "laboratory":

Random entries